Status:
WITHDRAWN
Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM
Lead Sponsor:
Assaf-Harofeh Medical Center
Collaborating Sponsors:
Sheba Medical Center
Kaplan Medical Center
Conditions:
T1DM
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
The incidence of T1DM in children, especially infants under 4 years of age, is increasing in the last decade. Not all patients are willing or able, from different reasons, to be treated with insulin p...
Detailed Description
study withdrawn Nor relevant
Eligibility Criteria
Inclusion
- Diagnosed with type 1 diabetes mellitus
- Insulin injection ≥2 per day for at least a week.
- Use of MDI insulin: Novorapid, Humalog or Apidra.
- Ability and willingness to perform at least 3 daily self-measured plasma glucose profiles
- Ability and willingness to adhere to the protocol. -
Exclusion
- Insulin pump use
- Mix insulin use -
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04428762
Start Date
May 1 2020
End Date
May 1 2020
Last Update
August 10 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.